Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2014

01.05.2014 | Epidemiology

Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study

verfasst von: Mandy Kiderlen, Nienke A. de Glas, Esther Bastiaannet, Willemien van de Water, Anton J. M. de Craen, Onno R. Guicherit, Jos W. S. Merkus, Martine Extermann, Cornelis J. H. van de Velde, Gerrit-Jan Liefers

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Older breast cancer patients often suffer from comorbid diseases, which may influence life expectancy. The aim of this study was to assess the impact of specific comorbidities on overall survival and distant recurrence free period (DRFP) of older breast cancer patients. Patients were included from the population-based FOCUS cohort which contains 3,672 breast cancer patients aged 65 years or older. The impact of comorbidity on overall survival and DRFP was analyzed using multivariable Cox proportional hazard models and Poisson regression models. Median follow-up time was 6.8 years (range 0–14.0). Irrespective of age; the number of comorbid diseases was significantly associated with worse overall survival [hazard ratio (HR) per increasing number of comorbid diseases: 1.20, 95 % confidence interval (CI) 1.13–1.27 and HR 1.09, 95 % CI 1.05–1.13 for age <75 and age ≥75, respectively]. Median follow-up time for DRFP was 5.7 years (range 0–14.0). An increasing number of comorbid diseases was associated with a decreasing risk of metastases among patients aged ≥75 (HR 0.94, 95 % CI 0.87–1.02), whereas an increasing risk was shown for patients aged <75 (HR 1.09, 95 % CI 1.01–1.19). This study shows that in older breast cancer, patients overall survival and DRFP are influenced by comorbidity. This reiterates that patient outcome is not only influenced by breast cancer, and non-cancer-related factors should be taken into account.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wildiers H, Kunkler I, Biganzoli L et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8:1101–1115PubMedCrossRef Wildiers H, Kunkler I, Biganzoli L et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8:1101–1115PubMedCrossRef
2.
Zurück zum Zitat Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13:e148–e160PubMedCrossRef Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13:e148–e160PubMedCrossRef
3.
Zurück zum Zitat Wildiers H, Mauer M, Pallis A et al (2013) End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer—Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology position article. J Clin Oncol 31:3711–3718PubMedCrossRef Wildiers H, Mauer M, Pallis A et al (2013) End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer—Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology position article. J Clin Oncol 31:3711–3718PubMedCrossRef
4.
Zurück zum Zitat Mell LK, Jeong JH, Nichols MA et al (2010) Predictors of competing mortality in early breast cancer. Cancer 116:5365–5373PubMedCrossRef Mell LK, Jeong JH, Nichols MA et al (2010) Predictors of competing mortality in early breast cancer. Cancer 116:5365–5373PubMedCrossRef
5.
Zurück zum Zitat van de Water W, Markopoulos C, van de Velde CJ et al (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307:590–597PubMed van de Water W, Markopoulos C, van de Velde CJ et al (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307:590–597PubMed
6.
Zurück zum Zitat Schairer C, Mink PJ, Carroll L et al (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311–1321PubMedCrossRef Schairer C, Mink PJ, Carroll L et al (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311–1321PubMedCrossRef
7.
Zurück zum Zitat Yancik R, Wesley MN, Ries LA et al (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885–892PubMedCrossRef Yancik R, Wesley MN, Ries LA et al (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885–892PubMedCrossRef
8.
Zurück zum Zitat van de Water W, Seynaeve C, Bastiaannet E et al (2013) Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist 18:8–13PubMedCentralPubMedCrossRef van de Water W, Seynaeve C, Bastiaannet E et al (2013) Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist 18:8–13PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380:37–43PubMedCrossRef Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380:37–43PubMedCrossRef
10.
Zurück zum Zitat Al-Refaie WB, Vickers SM, Zhong W et al (2011) Cancer trials versus the real world in the United States. Ann Surg 254:438–442PubMedCrossRef Al-Refaie WB, Vickers SM, Zhong W et al (2011) Cancer trials versus the real world in the United States. Ann Surg 254:438–442PubMedCrossRef
11.
Zurück zum Zitat Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067PubMedCrossRef Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067PubMedCrossRef
12.
Zurück zum Zitat World Health Organization (2012) The international statistical classification of diseases and related health problems ICD-10 World Health Organization (2012) The international statistical classification of diseases and related health problems ICD-10
13.
Zurück zum Zitat Conference communication: age categorization proposed at oral session, accessible for members only. Discussed at: International Society of Geriatric Oncology annual meeting; Berlin, Germany, 15–17 Oct 2009 Conference communication: age categorization proposed at oral session, accessible for members only. Discussed at: International Society of Geriatric Oncology annual meeting; Berlin, Germany, 15–17 Oct 2009
14.
Zurück zum Zitat Patnaik JL, Byers T, Diguiseppi C et al (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103:1101–1111PubMedCentralPubMedCrossRef Patnaik JL, Byers T, Diguiseppi C et al (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103:1101–1111PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Land LH, Dalton SO, Jensen MB et al (2012) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008. Breast Cancer Res Treat 131:1013–1020PubMedCrossRef Land LH, Dalton SO, Jensen MB et al (2012) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008. Breast Cancer Res Treat 131:1013–1020PubMedCrossRef
16.
Zurück zum Zitat Ording AG, Cronin-Fenton DP, Jacobsen JB et al (2013) Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study. Clin Epidemiol 5:39–46PubMedCentralPubMedCrossRef Ording AG, Cronin-Fenton DP, Jacobsen JB et al (2013) Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study. Clin Epidemiol 5:39–46PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Patnaik JL, Byers T, Diguiseppi C et al (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13:R64PubMedCentralPubMedCrossRef Patnaik JL, Byers T, Diguiseppi C et al (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13:R64PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Siegelmann-Danieli N, Khandelwal V, Wood GC et al (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7:59–66PubMedCrossRef Siegelmann-Danieli N, Khandelwal V, Wood GC et al (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7:59–66PubMedCrossRef
19.
Zurück zum Zitat Janssen-Heijnen ML, Houterman S, Lemmens VE et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231–240PubMedCrossRef Janssen-Heijnen ML, Houterman S, Lemmens VE et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231–240PubMedCrossRef
20.
Zurück zum Zitat Janssen-Heijnen MLG, Szerencsi K, van de Schans SAM et al (2010) Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 76:196–207PubMedCrossRef Janssen-Heijnen MLG, Szerencsi K, van de Schans SAM et al (2010) Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 76:196–207PubMedCrossRef
21.
Zurück zum Zitat Houterman S, Janssen-Heijnen ML, Verheij CD et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90:2332–2337PubMedCentralPubMed Houterman S, Janssen-Heijnen ML, Verheij CD et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90:2332–2337PubMedCentralPubMed
22.
Zurück zum Zitat Ring A, Sestak I, Baum M et al (2011) Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen alone or in combination trial. J Clin Oncol 29:4266–4272PubMedCrossRef Ring A, Sestak I, Baum M et al (2011) Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen alone or in combination trial. J Clin Oncol 29:4266–4272PubMedCrossRef
23.
Zurück zum Zitat Harris EE, Hwang WT, Urtishak SL et al (2008) The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 70:1453–1459PubMedCrossRef Harris EE, Hwang WT, Urtishak SL et al (2008) The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 70:1453–1459PubMedCrossRef
24.
Zurück zum Zitat Louwman WJ, Janssen-Heijnen ML, Houterman S et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41:779–785PubMedCrossRef Louwman WJ, Janssen-Heijnen ML, Houterman S et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41:779–785PubMedCrossRef
25.
Zurück zum Zitat Pal SK, Katheria V, Hurria A (2010) Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 60:120–132PubMedCrossRef Pal SK, Katheria V, Hurria A (2010) Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 60:120–132PubMedCrossRef
26.
Zurück zum Zitat Hamaker ME, Jonker JM, de Rooij SE et al (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13:e437–e444PubMedCrossRef Hamaker ME, Jonker JM, de Rooij SE et al (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13:e437–e444PubMedCrossRef
27.
Zurück zum Zitat Raji MA, Kuo Y-F, Freeman JL et al (2008) Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med 168:2033–2040PubMedCentralPubMedCrossRef Raji MA, Kuo Y-F, Freeman JL et al (2008) Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med 168:2033–2040PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Robb C, Boulware D, Overcash J et al (2010) Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol 74:218–224PubMedCrossRef Robb C, Boulware D, Overcash J et al (2010) Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol 74:218–224PubMedCrossRef
29.
Zurück zum Zitat Ording AG, Garne JP, Nystrom PM et al (2013) Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis—a Danish nationwide matched cohort study. PLoS One 8:e76013PubMedCentralPubMedCrossRef Ording AG, Garne JP, Nystrom PM et al (2013) Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis—a Danish nationwide matched cohort study. PLoS One 8:e76013PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Hamaker ME, Hamelinck VC, van Munster BC et al (2012) Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc 13:464–469PubMedCrossRef Hamaker ME, Hamelinck VC, van Munster BC et al (2012) Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc 13:464–469PubMedCrossRef
31.
Zurück zum Zitat Lin TL, Kuo MC, Shih LY et al (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91:1383–1391PubMedCrossRef Lin TL, Kuo MC, Shih LY et al (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91:1383–1391PubMedCrossRef
Metadaten
Titel
Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study
verfasst von
Mandy Kiderlen
Nienke A. de Glas
Esther Bastiaannet
Willemien van de Water
Anton J. M. de Craen
Onno R. Guicherit
Jos W. S. Merkus
Martine Extermann
Cornelis J. H. van de Velde
Gerrit-Jan Liefers
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2917-7

Weitere Artikel der Ausgabe 1/2014

Breast Cancer Research and Treatment 1/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.